Coldstream Capital Management Inc Beam Therapeutics Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 220 shares of BEAM stock, worth $4,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
220Holding current value
$4,012% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BEAM
# of Institutions
259Shares Held
84.9MCall Options Held
482KPut Options Held
230K-
Vanguard Group Inc Valley Forge, PA8.87MShares$162 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.48MShares$155 Million1.79% of portfolio
-
Farallon Capital Management LLC San Francisco, CA8.24MShares$150 Million1.09% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$139 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$82.8 Million70.85% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.28B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...